Document Detail

Cephalin as an efficient fusogen in hybridoma technology: can it replace poly ethylene glycol?
MedLine Citation:
PMID:  17979545     Owner:  NLM     Status:  MEDLINE    
In this study we set up a simple, fast, and highly efficient protocol to fuse cells and produce human hybridoma using non-toxic cephalin as a fusogenic lipid. We compared our proposed method with PEG-mediated fusion, the well-known conventional method. Human lymphoblastoid cells were fused with an F3B6 heteromyeloma cell line using cephalin or PEG as the fusogenic compound. The viability of the cells and their fusion rate were determined microscopically and hybridoma (antigen-specific and non-specific) production yield was calculated following HAT selection and screening. The fusion rates of cells in cephalin and PEG-mediated methods were comparable (25.9+/-5.73% versus 27.3+/-6.07%) while the viability of the cells immediately and after overnight incubation was obviously greater in the cephalin method than in the PEG (p<0.001). Our proposed cephalin-mediated cell fusion method is about five times more efficient than PEG in production of hybridoma clones; thus it may dismiss PEG as the most generalized fusogen in the future.
Reza Golestani; Ali Akbar Pourfathollah; Seyed Mohammad Moazzeni
Related Documents :
19712955 - Characterization of the plasma membrane localization and orientation of hpv16 e5 for ce...
16558035 - Comparative production of interferon by human fetal, neonatal, and maternal cells.
9851525 - Survival strategies of leishmania donovani in mammalian host macrophages.
118975 - Specific contact-dependent cell-to-cell communication during preconjugant interactions ...
2998905 - Involvement of cyclic amp, iodide and metabolites of arachidonic acid in the regulation...
19887125 - Multiscale three-dimensional scaffolds for soft tissue engineering via multimodal elect...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Studies    
Journal Detail:
Title:  Hybridoma (2005)     Volume:  26     ISSN:  1554-0014     ISO Abbreviation:  Hybridoma (Larchmt)     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-11-05     Completed Date:  2008-01-11     Revised Date:  2008-05-28    
Medline Journal Info:
Nlm Unique ID:  101241539     Medline TA:  Hybridoma (Larchmt)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  296-301     Citation Subset:  IM    
Department of Immunology, Tarbiat Modarres University, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Fusion
Cell Line
Cell Survival / drug effects
Hybridomas* / drug effects
Phosphatidylethanolamines* / toxicity
Polyethylene Glycols* / toxicity
Reg. No./Substance:
0/Phosphatidylethanolamines; 0/Polyethylene Glycols

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of an ovarian cancer anti-idiotype antibody (6B11VLVHCH3) in Chinese hamster ovary (CHO) ...
Next Document:  Production of monoclonal antibodies against Neisseria meningitidis using popliteal lymph nodes and i...